These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 15643240

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
    Sarosdy MF.
    Cancer; 2007 Feb 01; 109(3):536-41. PubMed ID: 17183557
    [Abstract] [Full Text] [Related]

  • 4. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
    Rhoden EL, Morgentaler A.
    Int J Impot Res; 2006 Feb 01; 18(2):201-5. PubMed ID: 16177827
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.
    Morgentaler A, Rhoden EL.
    Urology; 2006 Dec 01; 68(6):1263-7. PubMed ID: 17169647
    [Abstract] [Full Text] [Related]

  • 6. Testosterone replacement in prostate cancer survivors with hypogonadal symptoms.
    Leibowitz RL, Dorff TB, Tucker S, Symanowski J, Vogelzang NJ.
    BJU Int; 2010 May 01; 105(10):1397-401. PubMed ID: 19912179
    [Abstract] [Full Text] [Related]

  • 7. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
    Grober ED, Lamb DJ, Khera M, Murthy L, Lipshultz LI.
    Int J Impot Res; 2008 May 01; 20(6):561-5. PubMed ID: 18843272
    [Abstract] [Full Text] [Related]

  • 8. Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement.
    Gerstenbluth RE, Maniam PN, Corty EW, Seftel AD.
    J Androl; 2002 May 01; 23(6):922-6. PubMed ID: 12399540
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of testosterone replacement therapy following radical prostatectomy.
    Khera M, Lipshultz LI.
    Urol Clin North Am; 2007 Nov 01; 34(4):549-53, vi. PubMed ID: 17983894
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer.
    Teloken C, Da Ros CT, Caraver F, Weber FA, Cavalheiro AP, Graziottin TM.
    J Urol; 2005 Dec 01; 174(6):2178-80. PubMed ID: 16280759
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical practice experience with testosterone treatment in men with testosterone deficiency syndrome.
    McLaren D, Siemens DR, Izard J, Black A, Morales A.
    BJU Int; 2008 Nov 01; 102(9):1142-6. PubMed ID: 18540933
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.